1. Home
  2. AIR vs NVAX Comparison

AIR vs NVAX Comparison

Compare AIR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIR
  • NVAX
  • Stock Information
  • Founded
  • AIR 1951
  • NVAX 1987
  • Country
  • AIR United States
  • NVAX United States
  • Employees
  • AIR N/A
  • NVAX N/A
  • Industry
  • AIR Aerospace
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AIR Industrials
  • NVAX Health Care
  • Exchange
  • AIR Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • AIR 2.3B
  • NVAX 2.0B
  • IPO Year
  • AIR 1988
  • NVAX 1995
  • Fundamental
  • Price
  • AIR $66.08
  • NVAX $7.32
  • Analyst Decision
  • AIR Strong Buy
  • NVAX Buy
  • Analyst Count
  • AIR 5
  • NVAX 6
  • Target Price
  • AIR $81.00
  • NVAX $17.83
  • AVG Volume (30 Days)
  • AIR 256.6K
  • NVAX 5.7M
  • Earning Date
  • AIR 12-19-2024
  • NVAX 11-12-2024
  • Dividend Yield
  • AIR N/A
  • NVAX N/A
  • EPS Growth
  • AIR N/A
  • NVAX N/A
  • EPS
  • AIR 1.81
  • NVAX N/A
  • Revenue
  • AIR $2,430,900,000.00
  • NVAX $885,193,000.00
  • Revenue This Year
  • AIR $17.43
  • NVAX N/A
  • Revenue Next Year
  • AIR $7.27
  • NVAX N/A
  • P/E Ratio
  • AIR $36.62
  • NVAX N/A
  • Revenue Growth
  • AIR 16.09
  • NVAX N/A
  • 52 Week Low
  • AIR $54.71
  • NVAX $3.53
  • 52 Week High
  • AIR $76.34
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • AIR 56.94
  • NVAX 25.43
  • Support Level
  • AIR $62.37
  • NVAX $8.84
  • Resistance Level
  • AIR $69.50
  • NVAX $10.39
  • Average True Range (ATR)
  • AIR 1.98
  • NVAX 0.66
  • MACD
  • AIR 0.79
  • NVAX -0.14
  • Stochastic Oscillator
  • AIR 69.71
  • NVAX 13.35

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in two segments namely Aviation Services and Expeditionary Services. The Aviation Services segment consists of aftermarket support and services businesses that provide spares and maintenance support for aircraft operated by it's commercial and government/defense customers. The Expeditionary Services segment consists of businesses that provide products and services supporting the movement of equipment and personnel by the U.S. Department of Defense, foreign governments, and non-governmental organizations. It generates a majority of its revenue from the Aviation Services Segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: